3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 45.90
+0.10 (0.22%)
Aug 12, 2025, 1:57 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 3.57 billion as of August 11, 2025. Its market cap has increased by 32.91% in one year.
Market Cap
3.57B
Enterprise Value
2.95B
Revenue
265.69M
Ranking
n/a
PE Ratio
35.23
Stock Price
45.90
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has increased from 2.74B to 3.57B, an increase of 30.29%. That is a compound annual growth rate of 5.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 3.57B | -30.52% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | 2.64B | -3.35% |
| Dec 25, 2020 | 2.74B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 203.96B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 88.98B |
| Lotus Pharmaceutical | 57.98B |
| Oneness Biotech | 31.13B |
| Polaris Group | 27.81B |
| Center Laboratories | 27.03B |
| Pegavision | 24.80B |